Although there has been no difference with DPP-4 inhibitors on fasting blood glucose, we have a lower post prandial blood glucose by 34.40 mg/dL in patients treated with DPP-4 inhibitors vs. placebo especially in patients with a BMI less than 25 kg/m2 and in new onset diabetes <3 years. Here, DPP4 is linked to diabetes mellitus.